Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis

Generalized Additive Models: An Introduction with R

Wood, S. N. (2017) · doi:10.1201/9781315370279 · Cited by 13,852

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear Models

Wood, S. N. (2010) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.1467-9868.2010.00749.x · Cited by 7,538

Genome-wide atlas of gene expression in the adult mouse brain

Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572

Generalized Additive Models

Wood, S. N. (2006) · doi:10.1201/9781420010404 · Cited by 4,953

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

A mesoscale connectome of the mouse brain

Oh, S. W., Harris, J. A., Ng, L., Winslow, B., Cain, N., Mihalas, S., Wang, Q., Lau, C., Kuan, L., Henry, A. M., et al. (2014) · Nature · doi:10.1038/nature13186 · Cited by 2,612

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563

Stable and Efficient Multiple Smoothing Parameter Estimation for Generalized Additive Models

Wood, S. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000980 · Cited by 2,046

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Glymphatic failure as a final common pathway to dementia

Nedergaard, M., & Goldman, S. A. (2020) · Science · doi:10.1126/science.abb8739 · Cited by 1,145

Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

Calabresi, P., Mechelli, A., Natale, G., Volpicelli‐Daley, L. A., Lazzaro, G. D., & Ghiglieri, V. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05672-9 · Cited by 930

Standardizing workflows in imaging transcriptomics with the abagen toolbox

Markello, R. D., Arnatkevičiūtė, A., Poline, J., Fulcher, B. D., Fornito, A., & Mišić, B. (2021) · eLife · doi:10.7554/elife.72129 · Cited by 548

Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases

Nixon, R. A., & Rubinsztein, D. C. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00757-5 · Cited by 435

Mechanisms of secretion and spreading of pathological tau protein

Brunello, C. A., Merezhko, M., Uronen, R.-L., & Huttunen, H. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03349-1 · Cited by 304

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

Borghammer, P. (2021) · Journal of Parkinson's Disease · doi:10.3233/jpd-202481 · Cited by 259

Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease

Panicker, N., Kam, T., Wang, H., Neifert, S., Chou, S.-C., Kumar, M., Brahmachari, S., Jhaldiyal, A., Hinkle, J. T., Akkentli, F., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.05.009 · Cited by 222

Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease

Calabresi, P., Lazzaro, G. D., Marino, G., Campanelli, F., & Ghiglieri, V. (2023) · Brain · doi:10.1093/brain/awad150 · Cited by 168

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

Vogel, J. W., Corriveau‐Lecavalier, N., Franzmeier, N., Pereira, J. B., Brown, J. A., Maaß, A., Botha, H., Seeley, W. W., Bassett, D. S., Jones, D. T., et al. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00731-8 · Cited by 180

Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult

Henderson, M. X., Sedor, S. F., McGeary, I., Cornblath, E. J., Peng, C., Riddle, D. M., Li, H. L., Zhang, B., Brown, H. J., Olufemi, M. F., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.12.004 · Cited by 150

Cell-to-Cell Transmission of Tau and α-Synuclein

Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M.-Y., & Trojanowski, J. Q. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.012 · Cited by 149

Prion-like spreading of Alzheimer’s disease within the brain’s connectome

Fornari, S., Schäfer, A., Jucker, M., Goriely, A., & Ellen Kuhl, A. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0356 · Cited by 145

The enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases

Lubben, N., Ensink, E., Coetzee, G. A., & Labrie, V. (2021) · Brain Communications · doi:10.1093/braincomms/fcab211 · Cited by 139

Local molecular and global connectomic contributions to cross-disorder cortical abnormalities

Hansen, J. Y., Shafiei, G., Vogel, J. W., Smart, K. A., Bearden, C. E., Hoogman, M., Franke, B., van Rooij, D., Buitelaar, J. K., McDonald, C. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32420-y · Cited by 130

Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis

Mukherjee, S., Sakunthala, A., Gadhe, L. G., Poudyal, M., Sawner, A. S., Kadu, P., & Maji, S. K. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167713 · Cited by 133

Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit

Tozzi, A., Sciaccaluga, M., Loffredo, V., Megaro, A., Ledonne, A., Cardinale, A., Federici, M., Bellingacci, L., Paciotti, S., Ferrari, E. S., et al. (2021) · Brain · doi:10.1093/brain/awab242 · Cited by 127

Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies

Cascella, R., Bigi, A., Cremades, N., & Cecchi, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04166-9 · Cited by 130

Initiation and progression of α-synuclein pathology in Parkinson’s disease

Tofaris, G. K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04240-2 · Cited by 126

Towards a biologically annotated brain connectome

Bazinet, V., Hansen, J. Y., & Mišić, B. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00752-3 · Cited by 118

α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease

Stuendl, A., Kraus, T., Chatterjee, M., Zapke, B., Sadowski, B., Moebius, W., Hobert, M. A., Deuschle, C., Brockmann, K., Maetzler, W., et al. (2021) · Movement Disorders · doi:10.1002/mds.28639 · Cited by 108

Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation

Mezias, C., Rey, N. L., Brundin, P., & Raj, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104623 · Cited by 105

Genetic, cellular, and connectomic characterization of the brain regions commonly plagued by glioma

Mandal, A. S., Romero-García, R., Hart, M. G., & Suckling, J. (2020) · Brain · doi:10.1093/brain/awaa277 · Cited by 104

Determinants of seeding and spreading of α-synuclein pathology in the brain

Henrich, M. T., Geibl, F. F., Harini, L., Stegmann, A., Giasson, B. I., Mao, X., Dawson, V. L., Dawson, T. M., Oertel, W. H., & Surmeier, D. J. (2020) · Science Advances · doi:10.1126/sciadv.abc2487 · Cited by 104

α-Synuclein pathology as a target in neurodegenerative diseases

Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 121

Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease

Delva, A., Weehaeghe, D. V., Koole, M. J. B., Laere, K. V., & Vandenberghe, W. (2020) · Movement Disorders · doi:10.1002/mds.28216 · Cited by 99

Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons

Tanudjojo, B., Shaikh, S. S., Fenyi, A., Bousset, L., Agarwal, D., Marsh, J., Zois, C. E., Heman-Ackah, S. M., Fischer, R., Sims, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23682-z · Cited by 94

Protein-protein interactions in neurodegenerative diseases: A conspiracy theory

Thompson, T., Chaggar, P., Ellen Kuhl, A., Goriely, A., & Initiative, A. D. N. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008267 · Cited by 97

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?

O’Hara, D. M., Pawar, G. N., Kalia, S. K., & Kalia, L. V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00577 · Cited by 89

Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential

Ferreira, N., Gram, H., Sorrentino, Z. A., Gregersen, E., Schmidt, S. I., Reimer, L., Betzer, C., Pérez-Gozalbo, C., Beltoja, M., Nagaraj, M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02316-0 · Cited by 86

The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding

Courte, J., Bousset, L., von Boxberg, Y., Villard, C., Melki, R., & Peyrin, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61757-x · Cited by 83

Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease

Wu, K., Xu, Q., Liu, Y., Feng, Y., Han, S., Zhang, Y.-R., Chen, S.-D., Guo, Y. X., Wu, B., Ma, L., et al. (2025) · Science · doi:10.1126/science.adp3645 · Cited by 85

Selective neuronal vulnerability in Parkinson's disease

González‐Rodríguez, P., Zampese, E., & Surmeier, D. J. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.005 · Cited by 80

Discovering a reaction–diffusion model for Alzheimer’s disease by combining PINNs with symbolic regression

Zhang, Z., Zou, Z., Ellen Kuhl, A., & Karniadakis, G. E. (2023) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2023.116647 · Cited by 80

Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology

Goralski, T. M., Meyerdirk, L. K., Breton, L., Brasseur, L., Kurgat, K., DeWeerd, D., Turner, L., Becker, K., Adams, M., Newhouse, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47027-8 · Cited by 79

Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts

Teil, M., Arotçarena, M.-L., Faggiani, E., Laferrière, F., Bézard, E., & Dehay, B. (2020) · Biomolecules · doi:10.3390/biom10030391 · Cited by 80

Animal models of brain-first and body-first Parkinson's disease

Berge, N. V. D., & Ulusoy, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105599 · Cited by 80

Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo

Wu, Q., Shaikh, M., Meymand, E. S., Zhang, B., Luk, K. C., Trojanowski, J. Q., & Lee, V. M. ‐. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02227-6 · Cited by 71

Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability

Tremblay, C., Rahayel, S., Vo, A., Morys, F., Shafiei, G., Abbasi, N., Markello, R. D., Gan‐Or, Z., Mišić, B., & Dagher, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab269 · Cited by 70

Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system

Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 75

The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease

Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 74

Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation

Kim, M. S., Ra, E. A., Kweon, S. H., Seo, B. A., Ko, H. S., Oh, Y., & Lee, G. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.015 · Cited by 72

Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates

Elfarrash, S., Jensen, N. M., Ferreira, N., Betzer, C., Thevathasan, J. V., Diekmann, R., Adel, M., Omar, N. M., Boraie, M. Z., Gad, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0865-5 · Cited by 70

Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns

Rahayel, S., Mišić, B., Zheng, Y., Liu, Z.-Q., Abdelgawad, A. A., Abbasi, N., Caputo, A., Zhang, B., Lo, A., Kehm, V. M., et al. (2021) · Brain · doi:10.1093/brain/awab440 · Cited by 67

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy

Schaser, A. J., Stackhouse, T. L., Weston, L. J., Kerstein, P. C., Osterberg, V. R., López, C. S., Dickson, D. W., Luk, K. C., Meshul, C. K., Woltjer, R. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01026-0 · Cited by 63

Hemispheric asymmetry in the human brain and in Parkinson’s disease is linked to divergent epigenetic patterns in neurons

Li, P., Ensink, E., Lang, S., Marshall, L. L., Schilthuis, M., Lamp, J. A., Vega, I. E., & Labrie, V. (2020) · Genome biology · doi:10.1186/s13059-020-01960-1 · Cited by 65

Nanomedicine-based immunotherapy for central nervous system disorders

Hanif, S., Muhammad, P., Chesworth, R., Rehman, F. U., Qian, R., Zheng, M., & Shi, B. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0429-z · Cited by 69

Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor

Cornblath, E. J., Li, H. L., Changolkar, L., Zhang, B., Brown, H. J., Gathagan, R. J., Olufemi, M. F., Trojanowski, J. Q., Bassett, D. S., Lee, V. M. Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg6677 · Cited by 66

Integrating multimodal and multiscale connectivity blueprints of the human cerebral cortex in health and disease

Hansen, J. Y., Shafiei, G., Voigt, K., Liang, E. X., Cox, S. M. L., Leyton, M., Jamadar, S. D., & Mišić, B. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002314 · Cited by 70

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance

Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63

α ‐Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC‐ SNCA Mice

Uemura, N., Ueda, J., Yoshihara, T., Ikuno, M., Uemura, M. T., Yamakado, H., Asano, M., Trojanowski, J. Q., & Takahashi, R. (2021) · Movement Disorders · doi:10.1002/mds.28512 · Cited by 61

Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome

Fornari, S., Schäfer, A., Ellen Kuhl, A., & Goriely, A. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110102 · Cited by 62

Neuronal identity defines α-synuclein and tau toxicity

Praschberger, R., Kuenen, S., Schoovaerts, N., Kaempf, N., Singh, J., Janssens, J., Swerts, J., Nachman, E., Calatayud, C., Aerts, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.033 · Cited by 66

Cognitive heterogeneity in Parkinson’s disease: A mechanistic view

Carceles‐Cordon, M., Weintraub, D., & Chen‐Plotkin, A. S. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.021 · Cited by 63

Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein

Guan, Y., Zhao, X., Liu, F., Yan, S., Wang, Y., Du, C., Cui, X., Li, R., & Zhang, C. X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00159 · Cited by 54

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease

Gracia, P., Camino, J. D., Volpicelli‐Daley, L. A., & Cremades, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218043 · Cited by 57

A framework For brain atlases: Lessons from seizure dynamics

Revell, A. Y., Silva, A. B., Arnold, T. C., Stein, J. M., Das, S. R., Shinohara, R. T., Bassett, D. S., Litt, B., & Davis, K. A. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.118986 · Cited by 53

Solving brain circuit function and dysfunction with computational modeling and optogenetic fMRI

Lee, J. H., Liu, Q., & Dadgar‐Kiani, E. (2022) · Science · doi:10.1126/science.abq3868 · Cited by 59

Pharmacological inhibition and knockdown of O‐GlcNAcase reduces cellular internalization of α‐synuclein preformed fibrils

Tavassoly, O., Yue, J., & Vocadlo, D. J. (2020) · FEBS Journal · doi:10.1111/febs.15349 · Cited by 52

Functional Connectomics and Disease Progression in Drug‐Naïve Parkinson's Disease Patients

Micco, R. D., Agosta, F., Basaia, S., Siciliano, M., Cividini, C., Tedeschi, G., Filippi, M., & Tessitore, A. (2021) · Movement Disorders · doi:10.1002/mds.28541 · Cited by 53

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease

Kulkarni, A. S., Burns, M. R., Brundin, P., & Wesson, D. W. (2022) · Brain Communications · doi:10.1093/braincomms/fcac165 · Cited by 48

Cerebro-cerebellar motor networks in clinical subtypes of Parkinson’s disease

Basaia, S., Agosta, F., Francia, A., Cividini, C., Balestrino, R., Stojković, T., Stanković, I., Marković, V., Sarasso, E., Gardoni, A., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00377-w · Cited by 50

Hijacking Endocytosis and Autophagy in Extracellular Vesicle Communication: Where the Inside Meets the Outside

Pedrioli, G., & Paganetti, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.595515 · Cited by 50

Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease

Nim, S., O’Hara, D. M., Corbi‐Verge, C., Perez‐Riba, A., Fujisawa, K., Kapadia, M., Chau, H., Albanese, F., Pawar, G. N., de Snoo, M. L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37464-2 · Cited by 46

Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing

Pérez‐Rodríguez, D., Kalyva, M., Leija‐Salazar, M., Lashley, T., Tarabichi, M., Chelban, V., Gentleman, S., Schottlaender, L., Franklin, H., Vasmatzis, G., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0873-5 · Cited by 51

A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model

Polinski, N. K. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212847 · Cited by 50

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

Henderson, M. X., Covell, D. J., Chung, C. H.-Y., Pitkin, R. M., Frasier, R. M., Decker, S. C., Riddle, D. M., Zhang, B., Gathagan, R. J., James, M. J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104712 · Cited by 46

Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses

Chen, H., Wang, K., Scheperjans, F., & Killinger, B. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105601 · Cited by 45

Neuronal Oscillations on Evolving Networks: Dynamics, Damage, Degradation, Decline, Dementia, and Death

Goriely, A., Ellen Kuhl, A., & Bick, C. (2020) · Physical Review Letters · doi:10.1103/physrevlett.125.128102 · Cited by 40

Network Diffusion Modeling Explains Longitudinal Tau PET Data

Schäfer, A., Mormino, E. C., & Ellen Kuhl, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.566876 · Cited by 42

Efficient coding in the economics of human brain connectomics

Zhou, D., Lynn, C. W., Cui, Z., Ćirić, R., Baum, G. L., Moore, T. M., Roalf, D. R., Detre, J. A., Gur, R. C., Gur, R. E., et al. (2021) · Network Neuroscience · doi:10.1162/netn_a_00223 · Cited by 39

The Evolution-Driven Signature of Parkinson’s Disease

Diederich, N. J., Uchihara, T., Grillner, S. E., & Goetz, C. G. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.05.001 · Cited by 39

Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body

Awa, S., Suzuki, G., Masuda‐Suzukake, M., Nonaka, T., Saito, M., & Hasegawa, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-04780-4 · Cited by 39

Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease

Yaribash, S., Mohammadi, K., & Sani, M. A. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01544-2 · Cited by 44

α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome

Wang, R., Sun, H., Ren, H., & Wang, G. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1756-9 · Cited by 38

Extracellular alpha-synuclein: Sensors, receptors, and responses

Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 38

Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson’s disease.

Bortolozzi, A., Manashirov, S., Chen, A., & Artigas, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107873 · Cited by 37

The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease

Caligiore, D., Giocondo, F., & Silvetti, M. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.007 · Cited by 40

Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress

Walter, L. A., Lin, Y., Halbrook, C. J., Chuh, K. N., He, L., Pedowitz, N. J., Batt, A. R., Brennan, C. K., Stiles, B. L., Lyssiotis, C. A., et al. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00560 · Cited by 40

Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies

Ebanks, K., Lewis, P. A., & Bandopadhyay, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01381 · Cited by 38

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease

Henderson, M. X., Henrich, M. T., Geibl, F. F., Oertel, W. H., Brundin, P., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105687 · Cited by 35

Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein

Elfarrash, S., Jensen, N. M., Ferreira, N., Schmidt, S. I., Gregersen, E., Vestergaard, M. V., Nabavi, S., Meyer, M., & Jensen, P. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252635 · Cited by 32

Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection

Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36

Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease

Yu, M., Risacher, S. L., Nho, K. T., Wen, Q., Oblak, A. L., Unverzagt, F. W., Apostolova, L. G., Farlow, M. R., Brosch, J. R., Clark, D. G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113691 · Cited by 36

Current insights and assumptions on α-synuclein in Lewy body disease

Leak, R. K., Clark, R. N., Abbas, M., Xu, F., Brodsky, J. L., Chen, J., Hu, X., & Luk, K. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02781-3 · Cited by 41

Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns

Asher, D. M., Belay, E. D., Bigio, E. H., Brandner, S., Brubaker, S. A., Caughey, B. W., Clark, B., Damon, I. K., Diamond, M. I., Freund, M. P., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa109 · Cited by 35

Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala

Chen, L., Nagaraja, C., Daniels, S. R., Fisk, Z. A., Dvorak, R., Meyerdirk, L. K., Steiner, J. A., Galvis, M. L. E., Henderson, M. X., Rousseaux, M. W. C., et al. (2022) · eLife · doi:10.7554/elife.78055 · Cited by 33

Mechanisms of Glucocerebrosidase Dysfunction in Parkinson’s Disease

Chatterjee, D., & Krainc, D. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168023 · Cited by 33

Learning interpretable dynamics of stochastic complex systems from experimental data

Gao, T.-T., Barzel, B., & Yan, G. F. (2024) · Nature Communications · doi:10.1038/s41467-024-50378-x · Cited by 32

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases

Sokratian, A., Zhou, Y., Tatli, M., Burbidge, K. J., Xu, E., Viverette, E., Donzelli, S., Duda, A. M., Yuan, Y., Li, H., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq3539 · Cited by 32

Network models to enhance the translational impact of cross-species studies

Brynildsen, J. K., Rajan, K., Henderson, M. X., & Bassett, D. S. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00720-x · Cited by 32

Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease

Gordevičius, J., Li, P., Marshall, L. L., Killinger, B. A., Lang, S., Ensink, E., Kuhn, N. C., Cui, W., Maroof, N., Lauria, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25474-x · Cited by 36

Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons

Yu, J., Zhao, Z., Li, Y., Chen, J., Huang, N., & Luo, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28838 · Cited by 32

Inflammation in Experimental Models of α ‐Synucleinopathies

Harms, A. S., Kordower, J. H., Sette, A., Arlehamn, C. S. L., Sulzer, D., & Mach, R. H. (2020) · Movement Disorders · doi:10.1002/mds.28264 · Cited by 31

Lewy pathology formation in patient-derived GBA1 Parkinson’s disease midbrain organoids

Frattini, E., Faustini, G., Lopez, G., Carsana, E. V., Tosi, M., Trezzi, I., Magni, M., Soldà, G., Straniero, L., Facchi, D., et al. (2024) · Brain · doi:10.1093/brain/awae365 · Cited by 31

Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity

Stoll, A. C., & Sortwell, C. E. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105804 · Cited by 29

Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo

Lackie, R. E., de Miranda, A. S., Lim, M. P., Novikov, V., Madrer, N., Karunatilleke, N. C., Rutledge, B. S., Tullo, S., Brickenden, A. M., Maitland, M. E. R., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02491-8 · Cited by 29

Physiological and pathological insights into exosomes in the brain

Li, X., 合肥230001，中国, 中., Zhang, J., Li, D., Wu, W., Xie, Z., Liu, Q., 合肥230036，中国, 安., 合肥230026，中国, 中., 合肥230001，中国, 中., et al. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.043 · Cited by 28

Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex

Koike, Y. M., Sugai, A., Hara, N., Itô, J., Yokoseki, A., Ishihara, T., Yamagishi, T., Tsuboguchi, S., Tada, M., Ikeuchi, T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02621-0 · Cited by 31

The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases

Tsafaras, G., & Baekelandt, V. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105806 · Cited by 28

Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms

Khan, A. F., & Iturria‐Medina, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03073-w · Cited by 31

Connectivity and vulnerability determine α-synuclein spread

Lemprière, S. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0251-8

[Re] Spread of alpha-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis

Paul, T. E., & Bourdenx, M. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.5379630

The connectome is necessary but not sufficient for the spread of alpha -synuclein pathology in ratsPreprint

Oliveira, M. A. P., Arreckx, S., Monte, D. A. D., Preciat, G., Ulusoy, A., & Fleming, R. M. T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/567222 · Cited by 3

Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading

Li, Y., Torok, J., Zhang, S., Ding, J. L., Wang, N., Lau, C., Kulkarni, S., Anand, C., Tran, J., Cheng, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202413052 · Cited by 5

Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation

Zheng, Y., Zhang, Y., Yau, Y. H. C., Zeighami, Y., Larcher, K. M.-H., Mišić, B., & Dagher, A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000495 · Cited by 119